Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

NCT03774446 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
13
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Cedars-Sinai Medical Center